Skip to main content
. 2015 May 26;106(7):875–882. doi: 10.1111/cas.12686

Fig 5.

Fig 5

Antitumor activity of imatinib (Imt) in vivo. (a) Weight of AXT cell-derived s.c. tumors in mice treated with adriamycin (ADR), imatinib, or both. (b) Proportion of Ki67+ cells determined by immunohistochemical (IHC) analysis of tumors from mice treated as in (a). Left, representative images of Ki67 staining. Right, quantification of Ki67 positivity. (c) Quantitative analysis for lung metastatic lesions in mice treated as in (a). Left, representative images of lung metastatic lesions. Right, quantitative data of metastatic area presented as box-and-whisker plots. $P < 0.05. NS, not significant.